Wall Street analysts expect Health Insurance Innovations, Inc. (NASDAQ:HIIQ) to announce sales of $53.75 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Health Insurance Innovations’ earnings, with the lowest sales estimate coming in at $52.33 million and the highest estimate coming in at $55.17 million. Health Insurance Innovations reported sales of $46.11 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 16.6%. The company is expected to report its next quarterly earnings results on Wednesday, November 1st.

On average, analysts expect that Health Insurance Innovations will report full-year sales of $53.75 million for the current financial year, with estimates ranging from $228.71 million to $229.30 million. For the next fiscal year, analysts anticipate that the company will report sales of $268.50 million per share, with estimates ranging from $260.94 million to $276.07 million. Zacks’ sales calculations are a mean average based on a survey of research firms that follow Health Insurance Innovations.

Health Insurance Innovations (NASDAQ:HIIQ) last issued its quarterly earnings results on Wednesday, August 2nd. The financial services provider reported $0.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.33 by $0.13. The business had revenue of $61.80 million for the quarter, compared to analysts’ expectations of $53.69 million. Health Insurance Innovations had a net margin of 5.56% and a return on equity of 22.89%. The business’s quarterly revenue was up 38.9% compared to the same quarter last year.

A number of research analysts have issued reports on the stock. ValuEngine lowered shares of Health Insurance Innovations from a “buy” rating to a “hold” rating in a research note on Monday, August 14th. Zacks Investment Research upgraded shares of Health Insurance Innovations from a “hold” rating to a “buy” rating and set a $33.00 price target on the stock in a research note on Friday, August 4th. Canaccord Genuity restated a “buy” rating and set a $39.00 price target on shares of Health Insurance Innovations in a research note on Wednesday. Craig Hallum restated a “buy” rating and set a $38.00 price target (up previously from $28.00) on shares of Health Insurance Innovations in a research note on Thursday, August 3rd. Finally, TheStreet upgraded shares of Health Insurance Innovations from a “c” rating to a “b-” rating in a research note on Monday, May 22nd. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. Health Insurance Innovations currently has an average rating of “Buy” and an average target price of $31.33.

COPYRIGHT VIOLATION NOTICE: “Health Insurance Innovations, Inc. (HIIQ) Expected to Announce Quarterly Sales of $53.75 Million” was originally reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/09/14/health-insurance-innovations-inc-hiiq-expected-to-announce-quarterly-sales-of-53-75-million.html.

Shares of Health Insurance Innovations (NASDAQ HIIQ) traded up 0.353% on Monday, hitting $21.325. 1,175,017 shares of the stock traded hands. The stock has a 50 day moving average of $31.17 and a 200 day moving average of $22.76. The company has a market cap of $265.90 million, a PE ratio of 17.253 and a beta of 0.65. Health Insurance Innovations has a one year low of $4.00 and a one year high of $37.38.

In other news, insider Sheldon Wang sold 26,421 shares of the stock in a transaction on Monday, June 19th. The shares were sold at an average price of $22.99, for a total value of $607,418.79. Following the sale, the insider now owns 262,577 shares in the company, valued at $6,036,645.23. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Bruce Telkamp sold 30,000 shares of the stock in a transaction on Tuesday, July 18th. The stock was sold at an average price of $26.68, for a total transaction of $800,400.00. Following the completion of the sale, the chief executive officer now owns 104,001 shares in the company, valued at approximately $2,774,746.68. The disclosure for this sale can be found here. Insiders sold 221,248 shares of company stock worth $6,203,127 in the last quarter. Company insiders own 30.00% of the company’s stock.

Several large investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC increased its stake in shares of Health Insurance Innovations by 68.3% in the second quarter. Renaissance Technologies LLC now owns 1,010,400 shares of the financial services provider’s stock worth $23,744,000 after acquiring an additional 410,197 shares during the period. Lyon Street Capital LLC increased its stake in shares of Health Insurance Innovations by 14.4% in the second quarter. Lyon Street Capital LLC now owns 627,079 shares of the financial services provider’s stock worth $14,736,000 after acquiring an additional 78,818 shares during the period. Russell Investments Group Ltd. acquired a new stake in shares of Health Insurance Innovations in the second quarter worth $14,467,000. Capital World Investors acquired a new stake in shares of Health Insurance Innovations in the second quarter worth $11,680,000. Finally, Dialectic Capital Management LP increased its stake in shares of Health Insurance Innovations by 39.7% in the first quarter. Dialectic Capital Management LP now owns 496,300 shares of the financial services provider’s stock worth $7,941,000 after acquiring an additional 141,083 shares during the period. Hedge funds and other institutional investors own 90.32% of the company’s stock.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Get a free copy of the Zacks research report on Health Insurance Innovations (HIIQ)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related companies with MarketBeat.com's FREE daily email newsletter.